GlassScriptPhysician profile
Peter Goljan
NPI 1750777157
$38,164.59
in general payments reported to CMS, 2019-2025
15 companies · $1,387 in 2025
The $1,387 reported for 2025 was more than what a typical Sports Medicine (Orthopaedic Surgery) provider received nationally (typical 2025 total: $686).
See the full distribution for Sports Medicine (Orthopaedic Surgery)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $602 · 2020: $22K · 2021: $5,693 · 2022: $3,793 · 2023: $4,418 · 2024: $273 · 2025: $1,387.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $3,274 · Food and Beverage: $2,804.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $3,273.54 |
| Food and Beverage | $2,803.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $21,338.16 | 2020-2025 | |
| Stryker Corporation | $4,399.54 | 2021-2025 | Inspace, Tritanium, Iconix |
| Smith+Nephew, INC. | $4,124.40 | 2020-2025 | Bioinductive Implant With Arthroscopic Delivery System - Medium, Novostitch |
| Seapearl East, INC | $3,179.36 | 2022-2025 | |
| Medical Device Business Services, INC. | $1,686.42 | 2021-2023 | N/A, Truespan Orthocord, Velys |
| Micromed INC | $1,200.00 | 2021 | |
| Medtronic USA, INC. | $601.60 | 2019 | |
| Depuy Synthes Sales INC. | $473.77 | 2021-2025 | Na, Milagro, Fms |
| Zimmer Biomet Holdings, INC. | $456.71 | 2022-2024 | Quattro |
| Miach Orthopaedics, INC. | $435.78 | 2022-2025 | |
| Bioventus LLC | $142.34 | 2022 | |
| Pacira Therapeutics, INC. | $62.88 | 2021 | |
| Avanos Medical | $29.73 | 2024 | Genvisc 850 Sodium Hyaluronate |
| Vericel Corporation | $19.90 | 2021 | |
| Endo Pharmaceuticals INC. | $14.00 | 2023 | Xiaflex |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Peter Goljan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.